Insider Trading & Ownership of Camille L. Bedrosian

Location: Novato, CA
Summary: The estimated net worth of Camille L. Bedrosian is at least $5,736,418 dollars as of 09 Mar 2026. Camille L. Bedrosian is the Chief Medical Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $3.79M. Camille L. Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $981.1K. Camille L. Bedrosian is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $543.1K. Camille L. Bedrosian is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $421.3K.
Signature: /s/ Joshua B. Cohen, as Attorney in Fact
All Insider Reports: All Insider Reports

Notify me when Camille L. Bedrosian files a new Insider Trading report.

Ownership of Camille L. Bedrosian

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
AMLX	Amylyx Pharmaceuticals, Inc.	Chief Medical Officer	$3,790,922	-$407,224	-9.7%	05 Mar 2026
RARE	Ultragenyx Pharmaceutical Inc.	EVP and Chief Medical Officer	$981,120			01 Mar 2023
CRNX	Crinetics Pharmaceuticals, Inc.	Director	$543,116			11 Jun 2025
RYTM	RHYTHM PHARMACEUTICALS, INC.	Director	$421,260			24 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.